Stryker | SYK - Betriebsergebnis

Aktienkurs
343.32
Täglich Wechseln
4.94 1.46%
Monatlich
-0.72%
Jährlich
-0.92%
Q2 Prognose
329.89




Betriebsergebnis Veränderung Datum
Abbott USD 1.85B 399M 2026-03
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.5B 348M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 6.62B 1.03B 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Olympus JPY 28B 5.56B 2025-12
Smith & Nephew USD 440M 50M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12